Sensus Healthcare Inc
NASDAQ:SRTS

Watchlist Manager
Sensus Healthcare Inc Logo
Sensus Healthcare Inc
NASDAQ:SRTS
Watchlist
Price: 8.89 USD -0.45% Market Closed
Market Cap: 145.7m USD
Have any thoughts about
Sensus Healthcare Inc?
Write Note

Sensus Healthcare Inc
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sensus Healthcare Inc
Accumulated Depreciation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
Sensus Healthcare Inc
NASDAQ:SRTS
Accumulated Depreciation
-$2m
CAGR 3-Years
1%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accumulated Depreciation
-$3.6B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Stryker Corp
NYSE:SYK
Accumulated Depreciation
-$3.5B
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Accumulated Depreciation
-$11.8B
CAGR 3-Years
-5%
CAGR 5-Years
-7%
CAGR 10-Years
-6%
Intuitive Surgical Inc
NASDAQ:ISRG
Accumulated Depreciation
-$1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sensus Healthcare Inc
Glance View

Market Cap
145.7m USD
Industry
Health Care

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 37 full-time employees. The company went IPO on 2016-06-03. The firm is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The firm uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The firm incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100 Plus and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100 Plus offers remote diagnostics solutions, including operation tracking.

SRTS Intrinsic Value
10.46 USD
Undervaluation 15%
Intrinsic Value
Price

See Also

What is Sensus Healthcare Inc's Accumulated Depreciation?
Accumulated Depreciation
-2m USD

Based on the financial report for Sep 30, 2024, Sensus Healthcare Inc's Accumulated Depreciation amounts to -2m USD.

What is Sensus Healthcare Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-11%

Over the last year, the Accumulated Depreciation growth was 6%. The average annual Accumulated Depreciation growth rates for Sensus Healthcare Inc have been 1% over the past three years , -11% over the past five years .

Back to Top